BELLICUM PHARMACEUTICALS, INC 4
4 · BELLICUM PHARMACEUTICALS, INC · Filed Jan 5, 2017
Insider Transaction Report
Form 4
Moseley Ken
Vice President
Transactions
- Award
Employee Stock Option (right to buy)
2017-01-03+11,250→ 11,250 totalExercise: $13.89Exp: 2027-01-02→ Common Stock (11,250 underlying) - Award
Restricted Stock Units
2017-01-03+6,250→ 6,250 total→ Common Stock (6,250 underlying)
Footnotes (3)
- [F1]25% of the shares subject to the stock option vest and become exercisable on January 3, 2018, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of BLCM common stock.
- [F3]The restricted stock units vest in four equal annual installments beginning January 3, 2018.